A new initiative that aims to measure and promote the inclusion of  “brain capital” as an economic indicator was launched at the World Economic Forum in Davos last week.  Advocates for the Global Brain Economy initiative, and a companion Global Brain Capital Index argue that using brain health as a development indicator can help spur […] Continue reading ->
One year after the United States announced its withdrawal from the World Health Organization, a former WHO Headquarters Staff Association President reflects on how presence, governance, and leadership shape influence in global health. In January 2024, I stood before the WHO’s Executive Board, chaired by Qatar’s Minister of Health, Dr. Hanan Mohammed Al Kuwari. I […] Continue reading ->
STRASBOURG – The European Parliament backed the EU’s Critical Medicines Act (CMA) on Tuesday in a decisive move to secure Europe’s pharmaceutical supply chains from geopolitical shocks. With an overwhelming majority of 503 votes in favour, 57 against, and 108 abstentions, MEPs endorsed a sweeping industrial policy designed to re-shore the production of active ingredients […] Continue reading ->
One year ago today (20 January), the Trump administration exploded the global health sector by immediately “pausing” all aid for 90 days – and dispensing with 83% of US Agency for International Development (USAID) projects six weeks later. Trillionaire Elon Musk and his Department of Government Efficiency (DOGE) “chainsawed” at USAID projects and contracts, folding […] Continue reading ->
LAGOS – On 6 January, literary icon Chimamanda Ngozi Adichie lost one of her 21-month-old twin boys at Euracare, an elite private hospital in Lagos, Nigeria. Adichie alleges “criminal negligence”, specifically an overdose of propofol and oxygen deprivation, leading to the death of her son, Nkanu Nnamdi. The hospital maintains it followed “international standards” and […] Continue reading ->
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading ->